Literature DB >> 19320738

Alternatively activated macrophages (M2 macrophages) in the skin of patient with localized scleroderma.

Nobuyo Higashi-Kuwata, Takamitsu Makino, Yuji Inoue, Motohiro Takeya, Hironobu Ihn.   

Abstract

Localized scleroderma is a connective tissue disorder that is limited to the skin and subcutaneous tissue. Macrophages have been reported to be particularly activated in patients with skin disease including systemic sclerosis and are potentially important sources for fibrosis-inducing cytokines, such as transforming growth factor beta. To clarify the features of immunohistochemical characterization of the immune cell infiltrates in localized scleroderma focusing on macrophages, skin biopsy specimens were analysed by immunohistochemistry. The number of cells stained with monoclonal antibodies, CD68, CD163 and CD204, was calculated. An evident macrophage infiltrate and increased number of alternatively activated macrophages (M2 macrophages) in their fibrotic areas were observed along with their severity of inflammation. This study revealed that alternatively activated macrophages (M2 macrophages) may be a potential source of fibrosis-inducing cytokines in localized scleroderma, and may play a crucial role in the pathogenesis of localized scleroderma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19320738     DOI: 10.1111/j.1600-0625.2008.00828.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  30 in total

Review 1.  Update on macrophages and innate immunity in scleroderma.

Authors:  Jennifer J Chia; Theresa T Lu
Journal:  Curr Opin Rheumatol       Date:  2015-11       Impact factor: 5.006

2.  Profibrotic Activation of Human Macrophages in Systemic Sclerosis.

Authors:  Rajan Bhandari; Michael S Ball; Viktor Martyanov; Dillon Popovich; Evelien Schaafsma; Saemi Han; Mohamed ElTanbouly; Nicole M Orzechowski; Mary Carns; Esperanza Arroyo; Kathleen Aren; Monique Hinchcliff; Michael L Whitfield; Patricia A Pioli
Journal:  Arthritis Rheumatol       Date:  2020-05-31       Impact factor: 10.995

3.  Serum Soluble CD163 and its association with various disease parameters in patients with systemic sclerosis.

Authors:  Waleed Ahmed Salah Eldeen Hassan; Eman Abd Elaleem Baraka; Basant Mohammed Elnady; Tahany Mahmoud Gouda; Nehad Fouad
Journal:  Eur J Rheumatol       Date:  2016-09-01

4.  Serum levels of soluble CD163 in patients with systemic sclerosis.

Authors:  Wakana Nakayama; Masatoshi Jinnin; Katsunari Makino; Ikko Kajihara; Takamitsu Makino; Satoshi Fukushima; Yuji Inoue; Hironobu Ihn
Journal:  Rheumatol Int       Date:  2010-12-01       Impact factor: 2.631

5.  Adventitial fibroblasts induce a distinct proinflammatory/profibrotic macrophage phenotype in pulmonary hypertension.

Authors:  Karim C El Kasmi; Steven C Pugliese; Suzette R Riddle; Jens M Poth; Aimee L Anderson; Maria G Frid; Min Li; Soni S Pullamsetti; Rajkumar Savai; Maria A Nagel; Mehdi A Fini; Brian B Graham; Rubin M Tuder; Jacob E Friedman; Holger K Eltzschig; Ronald J Sokol; Kurt R Stenmark
Journal:  J Immunol       Date:  2014-06-13       Impact factor: 5.422

6.  Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype.

Authors:  Susan K Mathai; Mridu Gulati; Xueyan Peng; Thomas R Russell; Albert C Shaw; Ami N Rubinowitz; Lynne A Murray; Jonathan M Siner; Danielle E Antin-Ozerkis; Ruth R Montgomery; Ronald A S Reilkoff; Richard J Bucala; Erica L Herzog
Journal:  Lab Invest       Date:  2010-04-19       Impact factor: 5.662

7.  Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis.

Authors:  Nobuyo Higashi-Kuwata; Masatoshi Jinnin; Takamitsu Makino; Satoshi Fukushima; Yuji Inoue; Faith C Muchemwa; Yuji Yonemura; Yoshihiro Komohara; Motohiro Takeya; Hiroaki Mitsuya; Hironobu Ihn
Journal:  Arthritis Res Ther       Date:  2010-07-05       Impact factor: 5.156

Review 8.  Gene expression profiling offers insights into the role of innate immune signaling in SSc.

Authors:  Michael E Johnson; Patricia A Pioli; Michael L Whitfield
Journal:  Semin Immunopathol       Date:  2015-07-30       Impact factor: 9.623

Review 9.  Mononuclear cells in liver fibrosis.

Authors:  Fabio Marra; Sara Aleffi; Sara Galastri; Angela Provenzano
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

10.  Gadolinium-based compounds induce NLRP3-dependent IL-1β production and peritoneal inflammation.

Authors:  Christian Schmidt-Lauber; Lukas Bossaller; Hani H Abujudeh; Gregory I Vladimer; Anette Christ; Katherine A Fitzgerald; Eicke Latz; Ellen M Gravallese; Ann Marshak-Rothstein; Jonathan Kay
Journal:  Ann Rheum Dis       Date:  2014-06-09       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.